Alamar, Hemab, Kailera, and Seaport advance IPOs

Pharmaphorum

The last few days have seen a flurry of biotech IPO news, with Alamar, Hemab, Kailera, and Seaport all pushing for Nasdaq listings.

CommercialRead full story